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We  present  a highly  sensitive  bioanalytical  microarray  assay  that enables  the  analysis  of  small  genomic
sample  material.  By  combining  an  optimized  cDNA  puriﬁcation  step  with  single  molecule  cDNA  detection
on  the microarray,  the  platform  has  improved  sensitivity  compared  to conventional  systems,  allowing
ampliﬁcation-free  determination  of expression  proﬁles  with  as  little  as 600  ng  total  RNA.  Total  RNA  from
cells was  reverse  transcribed  into  ﬂuorescently  labeled  cDNA  and  puriﬁed  employing  a  precipitation
method  that  minimizes  loss  of  cDNA  material.  The microarray  was  scanned  on  a ﬂuorescence  chip-xpression proﬁling
icroarray
ubpopulation analysis
ingle molecule detection
luorescence microscopy
reader  with  single  molecule  sensitivity.  Using  the  newly  developed  platform  we were  able  to  analyze
the  RNA  expression  proﬁle  of a subpopulation  of rare  multiple  myeloma  CD138  negative  progenitor  (MM
CD138neg)  cells.  The  high-sensitivity  microarray  approach  led  to the  identiﬁcation  of a set  of 20 genes  dif-
ferentially  expressed  in  MM  CD138neg cells.  Our  work  demonstrates  the  applicability  of a straight-forward
single-molecule  DNA  array  technology  to  current  topics  of molecular  and  cellular  cancer  research,  which
are otherwise  difﬁcult  to address  due  to  the  limited  amount  of sample  material.. Introduction
Microarrays have become the paramount tool for compara-
ive global analysis of biological samples. Yet, current technology
equires relatively large amounts of sample material, which ham-
ers the speciﬁc analysis of complex and heterogeneous biological
issues. These technological limitations are converse to the emerg-
ng interest in gene regulation of rare cellular subpopulations. Most
esearchers therefore revert to polymerase chain reaction (PCR) or
NA polymerase-based ampliﬁcation to increase the signal on the
icroarray.
In recent years, a few ampliﬁcation-based approaches wereeveloped particularly for expression analysis of small RNA sam-
les. In 2006 Kurimoto et al. established a method for RNA
xpression proﬁling that relies on a combination of robust, strongly
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controlled PCR ampliﬁcation and microarray-based quantiﬁcation.
They were able to perform expression proﬁling even of a single
cell (Kurimoto et al., 2006). However many controls were required
to guarantee the linearity of the sample ampliﬁcation rendering
this method laborious and time consuming. Marcus et al. devel-
oped a microﬂuidic device for parallel RT-qPCR quantiﬁcation of
72 RNA samples. Using few ampliﬁcation steps they were able to
detect low abundant mRNA templates making the assay useful for
analysis of small populations (Marcus et al., 2006) and even sin-
gle neurons (Citri et al., 2011). The required ampliﬁcation steps,
however, have the disadvantage that the native expression levels
may  be distorted (Bustin, 2000) (Bustin and Nolan, 2004), rendering
unbiased expression proﬁling of small cell populations still difﬁcult.
Also sequencing approaches were adapted for RNA-expression
proﬁling (RNA-Seq) (Wang et al., 2009) (Brooks et al., 2011). Here,
the RNA population is converted into cDNA fragments and analyzed
using deep sequencing technology. The procedure is very robust
and sensitive, with a requirement of only 20 ng of total RNA, though
it is still prohibitively expensive for many laboratories.
Open access under CC BY-NC-ND license.As an alternative approach we have developed a single molecule
readout platform for the quantiﬁcation of small amounts of cDNA
in a massively parallel format without the need for prior sample
ampliﬁcation (Hesse et al., 2006). The ultra-sensitive biochips allow
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or competitive analysis of over 2000 target genes simultaneously,
equiring only 200 ng of total RNA, which is extremely demanding
or parallel PCR approaches (Hesse et al., 2006; Marcus et al., 2006).
he novel analysis method relies on direct single molecule count-
ng, making it independent of labeling efﬁciency or label brightness.
t allows for accurate background rejection and gives precise infor-
ation on the number of molecules speciﬁcally hybridized to the
icroarray spots. As an additional advantage, the array costs and
otal RNA handling efforts are comparably low.
We demonstrated the potential of the single molecule microar-
ay platform by recording the expression proﬁle of multiple
yeloma CD138 negative progenitor (MM  CD138neg) cells. Mul-
iple myeloma (MM)  is a malignant and basically incurable disease
haracterized by uncontrolled proliferation of CD138pos clonal
lasma cells. Previous studies have shown that MM comprises
wo populations of plasma cells with distinct malignant properties.
he majority of MM cells is CD138pos and displays a differenti-
ted phenotype, while a rare subpopulation of MM CD138neg cells
hows features of cancer stem cells (CSCs) including self-renewal,
lonogenic growth and tumor initiation upon transplantation into
mmunodeﬁcient recipient mice (Matsui et al., 2004). Using the
eveloped single molecule microarray platform we  characterized
he human MM cell line NCI-H929 cells on a molecular level
nd identiﬁed a set of genes differentially expressed in the rare
D138neg subpopulation.
. Materials and methods
.1. Cell culture and FACS analysis
NCI-H929 cells were grown as described previously (Matsui
t al., 2004) in RPMI1640 media (PAA), 10% fetal bovine serum
FBS; PAA), penicillin (62.5 g/ml) and streptomycin (100 g/ml)
t 37 ◦C in a humidiﬁed atmosphere of 5% CO2. NCI-H929 cells
ATCC) were initially depleted for necrotic cells by density centrifu-
ation. CD138 cell surface staining was carried out in phosphate
uffered saline (PBS) containing 0.5% FBS (PAA) plus 2 mM EDTA for
0 min  at room temperature with phycoerythrin (PE) conjugated
ouse anti human CD138 antibody (BD Pharmingen; Cat: 552026)
n combination with 7AAD (BD Pharmingen) to exclude dead cells.
luorescence activated cell sorting into CD138pos and CD138neg
opulations was done on a BD-FACS-vantage machine (Matsui et al.,
004). Speciﬁcity of CD138-PE negatively stained cells was coun-
erchecked via usage of an isotype control whereas intensity of PE
ignal was checked by speciﬁc control staining of Jurkat (ATCC)
ells via usage of anti human CD3-PE antibody (ImmunoTools; Cat:
1270034).
Doxycycline inducible GLI expressing HaCaT cells were grown
n HEPES-buffered DMEM (pH 7.2), containing 10% FCS, 100 mg/l
treptomycin and 62.5 mg/l penicillin at 37 ◦C. GLI expression was
nduced by adding to the culture media tetracycline (Invitrogen) to
 ﬁnal concentration of 1 g/ml. (Regl et al., 2002). Total RNA was
arvested after 48 h of tetracycline treatment.
.2. RNA isolation
Total RNA isolation was carried out using the phenol-free
NAqueous® Technology (Ambion; AM1912). From the sorted
06 cells of the CD138neg population of the NCI-H929 cell line an
mount of 2 g of total RNA could be isolated. 106 cells of the
D138pos population obtained in the same FACS run were used to
solate 2 g total RNA for comparative analysis. 600 ng total RNA
f each population were used for screening for alterations in gene
xpression, 1.4 g for validation of determined genes of interest.logy 164 (2013) 525– 530
2.3. cDNA preparation
In brief, 20 g, 5 g or 0.6 g of total RNA were reverse tran-
scribed with Superscript II (Invitrogen Life Technologies) in the
presence of Alexa Fluor 555-aha-dUTP or Alexa Fluor 647-aha-dUTP
(Molecular Probes, Invitrogen). When cDNA obtained from 1 g
RNA was puriﬁed using afﬁnity columns according to the man-
ufacturer’s instructions, no microarray signal could be detected.
Therefore, we  used a precipitation approach for cDNA preparation.
The method is based on ammonium acetate and linear polyacryl-
amide (LPA, GenElute) precipitation of the DNA, which is effective
in dNTP depletion and recovery of larger DNA fragments. In the
ﬁrst step, the 60 l (0.025 M NaCl) feedstock from the hydroly-
sis reaction (kit speciﬁc RNA degradation reaction) was incubated
with 17.5 l 10 M ammonium acetate (2–2.5 M in the hydrolysis
solution). Second, 2.5 l LPA was  added to the hydrolysis solution
(0.6 mg/l of LPA). The solution was mixed in 160 l of ethanol
(96%, 2× total volume) and incubated on ice for 30 min. To purify
the cDNA and separate free nucleotides and dye molecules, the
sample was centrifuged with ∼14.000 × g and the supernatant was
removed carefully. Finally, the sample was washed with 200 l of
70% ethanol, centrifuged with ∼18.000 × g for 5 min  and dried after
discarding the supernatant. The remaining pellet was  re-suspended
in 15 l H2O.
2.4. Hybridization
Labeled and puriﬁed cDNA adjusted to 3xSSC (3x Saline-Sodium
Citrate: 45 mM sodium citrate, 450 mM NaCl, pH 7.4)/0.1% SDS
(Sodium Dodecyl Sulfate) buffer was  heated to 96 ◦C for 3 min and
subsequently hybridized for 16 h at 50 ◦C under a LifterSlip (Erie
Scientiﬁc Company). During hybridization the sample was perma-
nently mixed in a hybridization station (SlideBooster, Advalytix
AG, mix./pause ratio 3:7, mix. power: 27). Afterwards the microar-
rays were washed in three sequential steps in 1xSSC/0.1% SDS,
0.1xSSC/0.1% SDS and ﬁnally 0.1xSSC each for 5 min  at RT. Prior
to ﬂuorescence readout, microarrays were covered with 0.1x SSC
buffer and sealed using hybridization chambers (Sigma–Aldrich,
Secure Seal, SA500) (Hesse et al., 2006).
2.5. Readout and microarray analysis
The biochip readout was  performed on a single molecule sensi-
tivity ﬂuorescence scanner described in detail before (Hesse et al.,
2006, 2004). Brieﬂy, the set up is based on an epiﬂuorescence
microscope (Axiovert 200, Zeiss) which is equipped with Ar+-
and Kr+-ion lasers (Innova, Coherent) for selective ﬂuorescence
excitation of Alexa Fluor 555 at 514 nm and Alexa Fluor 647 at
647 nm,  respectively. The samples were illuminated in objective-
type total internal reﬂection (TIR) conﬁguration using a 100x oil
immersion objective (NA = 1.45, -Fluar, Zeiss). Fluorescence light
is collected using the same objective and, after appropriate ﬁltering
using standard Cy3 and Cy5 ﬁlter sets (Chroma Technology Corp.),
imaged onto a back-illuminated CCD camera (SPEC10:100B, Prince-
ton Instruments; quantum efﬁciency = 90%, gain = 0.77 counts/e−).
For large area readout the scanner was operated in time-delay
and integration- (TDI-) mode and equipped with a focus hold sys-
tem that maintains the focal position during imaging (Hesch et al.,
2009).
For measuring the speciﬁc hybridization of labeled cDNA, the
microarrays were scanned at 200 nm resolution with an excita-
tion intensity of 0.12 kW/cm2 and an integration time per pixel of
116 ms.  After readout of the speciﬁc hybridization signal, the arrays
were stained with labeled random hexamer oligonucleotides (Sup-
plementary), and the slides were imaged at low resolution using
a hardware binning of 10. These low resolution images were used
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Fig. 1. Fluorescence images of a 1.4 cm ×2.4 cm microarray (upper row) after hybridization of HaCaT cDNA labeled with Alexa Fluor 555 (left column) and Alexa Fluor 647
(right  column); the whole array was scanned with 200 nm resolution. The columns in the magniﬁed image regions (A and B) show replicate spots of a few different genes.
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or obtaining the spot coordinates. For each spot sub-images were
enerated and analyzed using an à trous wavelet based peak count-
ng approach (Muresan et al., 2010). More detailed analysis of peak
haracteristics (brightness and width) conﬁrmed that these signals
riginated from individual hybridized cDNA molecules (Hesse et al.,
006). The majority of spots showed only low number of peaks
orresponding to a weak hybridization signal.
.6. qPCR analysis
The sequences of the primers used for ampliﬁcation are
isted in the supplemental material section (Supplementary table
1). Primers used that are not listed in table S1 were as
eferred (Schnidar et al., 2009). Primer design was  done with
rimer3 v. 0.4.0 online software via usage of standardized primer
length: 20–27 bp; Tm:  70–72 ◦C) and product size (100–200 bp)
arameters. Comparative qPCR analysis was carried out on a Rotor-
ene3000 (Corbett Research) using SYBR-Green-Supermix (BioRad
aboratories). Large ribosomal protein P0 (RPLP0) was used as a
eference for normalization (Martin et al., 2001).
. Results
In order to optimize imaging conditions and preparation steps
or the minute sample size of MM CD138neg cells, we performed
est experiments using a Tetracycline (Tet)-inducible human kera-
inocyte cell line (HaCaT) expressing the GLI oncogene under
et-control (Regl et al., 2004). Differences in gene expression
etween Tet-treated (GLI expressing) and untreated (GLI-negative)rs. The highest magniﬁcation (C and D) shows two  spots with different densities of
samples were analyzed by competitive two-color microarray
hybridization experiments.
We previously developed a method, which enables expression
proﬁling with tiny amounts of only 104 cells with a detection
limit of 1.3 fM (∼39,000 target molecules/sample volume 50 l)
(Hesse et al., 2006). Here we ﬁrst extended this platform to
two color analysis. Alexa Fluor 647 and Alexa Fluor 555 labeled
cDNA was synthesized from 5 g total RNA isolated from Tet-
treated and untreated control cells, respectively. 4% of the puriﬁed
cDNA–equivalent to 200 ng total RNA – was  used for hybridization
to custom-made microarrays (Supplementary), which contained a
set of 120 genes with >60 replicates taken from the Human Genome
Oligo Set V3 (Operon). After hybridization over night, unbound
sample was  removed by a series of washing steps.
The microarrays were scanned sequentially in the red and
the green channel, yielding images of 1.4 cm × 2.4 cm size at
diffraction-limited resolution and single molecule sensitivity
(Fig. 1). Single molecule counting was performed as described
in (Muresan et al., 2010). Subsequently, we applied a second
hybridization that stained all spots with 1 nM ﬂuorescent random
hexamer sequences (Supplement Array stain & Signal Ampliﬁca-
tion for Gridding), and rescanned the same area again. These images
were used to localize all spots on the microarray.
To account for potential inﬂuences of the ﬂuorophore on the
hybridization and labeling efﬁciency, a color-swap was performed.
Three technical replicates were recorded for each sample/dye com-
bination using cDNA from the same reverse transcription. For
comparison a conventional comparative analysis was performed
on a commercial system (Corning slides, Perkin Elmer reader) with
528 J. Jacak et al. / Journal of Biotechnology 164 (2013) 525– 530
Fig. 2. Correlation plot of expression proﬁling ratios obtained from the ultrasensi-
tive  platform (200 ng total RNA) and a commercial microarray (20 g total RNA).
29  gene ratios of Tetratcycline treated/untreated HaCaT cells detected at the single
molecule level were compared. The diagram shows a high correlation of gene ratios
with a Pearson correlation coefﬁcient of 0.85. The black dots show ratios between
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Fig. 3. Correlation of the gene expression levels between sample preparations
using 5 g and 600 ng total RNA as starting material. For both conditions, cDNAata obtained using Alexa Fluor 647 with Tet-treated cells and Alexa Fluor 555 with
ntreated cells. The open rectangles represent the ratios determined after a color
wap using the opposite sample-dye combination.
DNA identically prepared from hundred-fold higher amounts of
otal RNA. The proﬁle obtained on the single molecule microarrays
orrelated well with the results obtained on the commercial plat-
orm. Moreover a color swap on the ultra-sensitive array did not
ave any inﬂuence on the correlation with the commercial platform
Pearson correlation of 0.85/0.81 respectively) (Fig. 2).
One major factor that limits the sensitivity in mRNA expres-
ion proﬁling is the loss of material during reverse transcription
nd puriﬁcation of the resulting cDNA (Bustin and Nolan, 2004;
arcus et al., 2006). Therefore standard methods for RNA prepa-
ation needed to be adapted for handling of minute amounts of
ample. To mimic  the limited amount of sample material, we have
educed the cell number to 104 HaCaT cells for RNA extraction.
sing the RNAqueous® kit, 600 ng total RNA could be obtained
nd was used for transcription into ﬂuorescently labeled (Alexa
luor 647 or Alexa Fluor 555) cDNA utilizing the Superscript II
it. To prevent loss of cDNA due to irreversible binding to chro-
atography puriﬁcation columns, we set up a precipitation-based
uriﬁcation approach using linear polyacrylamide (LPA) as matrix.
he high yield of this method allowed splitting the puriﬁed cDNA
nto three sub-samples and hybridizing each of them to separate
icroarrays. We  used from here on a selection of 2086 genes
rom the Operon human signal transduction set (Supplementary
ene list.xls). The signal intensities obtained from the technical
eplicates show excellent correlation with signals obtained using
 g total RNA puriﬁed classically and detected on the ultrasensi-
ive platform (Pearson correlation coefﬁcient ∼0.9, Fig. 3).
We then used the new method for mRNA expression proﬁl-
ng in multiple myeloma (MM)  cancer stem cells. MM CD138neg
ells were isolated from the total population via FACS based on
he lack in surface expression of CD138 (Huff and Matsui, 2008;
rivtsov et al., 2009; Matsui et al., 2004; Peacock et al., 2007). The
D138neg subpopulation resembled ∼2.5% of the total NCI-H929
opulation and only 2.500 cells could be collected per sorting run.
o get enough material for one experiment multiple FACS runs were
ooled prior to RNA extraction. For validation of FACS selection,
he isolated cells were tested for differential expression of Hedge-
og (HH) downstream signaling targets. The RNA obtained from
D138neg and CD138pos cells was labeled with Alexa Fluor 647 and
ith Alexa Fluor 555, respectively, and competitively hybridizedcorresponding to 200 ng total RNA from the Alexa Fluor 647 labeled cDNA from Tet-
treated HaCaT cells was used for hybridization. The determined expression levels
show a Pearson correlation coefﬁcient of 0.9.
on chips spotted with the human signal transduction set repre-
senting 2086 genes as described above (Fig. 4). Due to the low
sample concentration, the average ﬂuorescence signal measured
on the microarray was  low, with many spots having just a few
molecules hybridized. Still, with the single molecule approach we
could unambiguously identify the hybridized molecules, as exem-
pliﬁed on the zooms shown in Fig. 4.
In the regime of very low binding probabilities a fair quantiﬁ-
cation of the detection limit needs to account for the stochasticity
of the binding process (Hesse et al., 2006). To ensure statistically
robust results, we  set a threshold of 100 molecules bound per spot
for ratiometric analysis. After applying the threshold more than 400
genes remained analyzable with the obtained expression levels and
correlated well between the technical replicates. The expression
ratios (CD138neg/CD138pos) of most of the genes were found to be
smaller than 2 meaning that genes are expressed at similar levels
in both cell populations. However, a strong alteration (>2 or <0.5)
could be found for a set of 25 genes.
For validation of these results, a subset of 20 targets with
strongly altered expression in CD138neg MM cells compared to
CD138pos was chosen (Table 1). For this, the remaining 1.4 g mRNA
was analyzed using qPCR. Of the 20 genes, the induction of 11
genes could be validated (genes marked with * in Table 1); 4 genes
gave diverging results and 5 genes could not be detected by qPCR.
The positively validated genes show a good accordance with the
microarray data.
4. Discussion
We  developed an inexpensive, robust and ampliﬁcation-free
ultrasensitive microarray assay for competitive hybridization,
which was  successfully applied to mRNA expression proﬁling of
MM CD138neg cells, a very rare subpopulation of self-renewing
tumor cells responsible for tumor growth, minimal residual disease
and patients’ relapse (Matsui et al., 2004). The key challenges of
the presented approach were of technical and biochemical nature:
J. Jacak et al. / Journal of Biotechnology 164 (2013) 525– 530 529
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Rig. 4. Array hybridized with cDNA reverse transcribed from 200 ng total RNA obt
olecule level. The zoomed out two colors scanned spots show sharp, randomly di
he platform required a two-color extension for the detection and
 robust analysis system capable of correct alignment and fast
nalysis of large arrays at single molecule level (Muresan et al.,
010). Moreover, while RNA isolation using standard kits worked
eliably, cDNA puriﬁcation using a commercial kit resulted in sub-
tantial loss of sample material. Using the human keratinocyte cell
ine HaCaT, we implemented a precipitation-based puriﬁcation,
hich, in combination with single molecule microarray analysis,
llowed ampliﬁcation-independent expression proﬁling with as
ittle as 200 ng total RNA corresponding to about 10.000 cells as
tarting material. The ratios obtained via molecule counting on
ingle molecule microarray data showed no dependency on the
abeling as differential labeling efﬁciencies do not distort the quan-
iﬁcation; here: a molecule is counted as long as it carries at least
ne dye label. This eliminates the commonly required color swap
xperiments further reducing the amount of biological material and
ime-consuming lab work.
The platform was used to analyze the gene expression proﬁle
f MM CD138neg cells found in the human cancer cell line NCI-
929. The low frequency at which CD138neg cells occur in tumor
amples rendered standard analysis approaches inappropriate in
able 1
atios between differentially expressed genes.
Gene name
(* –
validated)
Array result
(CD138neg/
CD138pos)
p-Value of
array results
qPCR result
(CD138neg/
CD138pos)
FGF18 * 17.43 ± 5.6 0.016 4.28
SMOH * 15.61 ± 0.53 0.002 25.99
DYRK3 * 9.16 ± 0.43 0.006 28.84
ABCB11 8.05 ± 3.61 0.013 Not detected
CYP19 * 6.82 ± 0.65 0.092 3.86
PRKAA1 * 6.21 ± 0.8 0.062 4.59
GNB2 5.68 ± 2.09 0.041 1.51
NFATC2 * 5.26 ± 0.32 0.007 2.92
PCDHB4  * 4.88 ± 2.28 0.008 50.21
GRB10 * 4.87 ± 0.44 0.020 2.22
CSEN 4.69 ± 3.3 0.219 1.15
KCNIP1 4.26 ± 2.2 0.040 Not detected
BLR1 4.25 ± 4 0.013 Not detected
KCNQ2 * 4.02 ± 0.58 0.014 7.21
MYO1C 3.96 ± 0.02 0.015 1.07
OSMR * 2.73 ± 0.52 0.006 9.19
PCDHB7  * 2.25 ± 0.75 0.046 2.14
CASQ1 0.45 ± 0.01 0.010 Not detected
CSNK1A1 0.33 ± 0.03 0.006 2
UBE2I 0.30 ± 0.02 0.004 Not detected from the NCI-H929 cell line. Most of the genes can only be detected at the single
ted single molecule signals with different densities.
terms of sensitivity. The single molecule microarray approach pro-
vided quantitative information on 400 genes represented in the
human signal transduction set. This yielded a set of 20 genes differ-
entially expressed between the CD138neg and CD138pos population.
Using qPCR, the altered expression of 11 genes could be validated, 4
genes showed contradictory results and 5 genes were not detected
in the qPCR analysis. This result demonstrates i) the high sensitiv-
ity of the single molecule platform and ii) the good correlation of
qualitative expression changes. However, we determined quantita-
tive differences in the differential mRNA expression between single
molecule microarray and qPCR analysis. This might be e.g. due to
unspeciﬁc hybridization on the microarray, variations in ampliﬁ-
cation efﬁciencies depending on the primer design as well as the
unspeciﬁc background signal of the SYBR Green technology used
for qPCR analysis (Morey et al., 2006).
Previous studies of have implicated the Hedgehog/GLI pathway
in the control of MM CSC (Ghosh and Matsui, 2009; Peacock et al.,
2007). Inhibition of the essential Hedgehog effector Smoothened
(SMO), a seven transmembrane domain protein with similari-
ties to G-proteins coupled receptors (Ayers and Therond, 2010),
prevents self-renewal and disease propagation of CD138neg MM
cells by promoting differentiation of CSC (Peacock et al., 2007).
In this context it is noteworthy that we  found high expression
of SMO  in the CD138neg population compared to CD138pos cells.
Together with high-level expression of the Hedgehog-regulated
transcription factor GLI1 and Hedgehog ligands (data not shown),
this suggests that MM CSC may  be preferentially sensitive to
SMO  antagonists, in analogy to the recent report showing that
high level SMO  expression has been correlated with sensitivity
of chronic lymphocytic leukemia cells to SMO  inhibitors (Decker
et al., 2012). Further, increased expression of the dual-speciﬁcity
tyrosine-phosphorylation regulated kinase 3 (DYRK3) points to an
additional layer of regulating Hedgehog signal strength in MM
CD138neg cells, as DYRK kinases are well known modiﬁers of
Hedgehog signaling by affecting the transcriptional activity of GLI
proteins (Mao  et al., 2002) (Varjosalo et al., 2008). In summary,
the gene expression proﬁle of MM CD138neg cells determined with
our single-molecule microarray platforms provides descriptive evi-
dence supporting an involvement of Hedgehog signaling in MM
CD138neg cells, an observation that warrants further experimental
investigations.On the technical side, the presented work clearly demonstrates
that the combination of single molecule microarray analysis with
an improved cDNA puriﬁcation method provides a powerful and
robust technology platform. It allows cost effective and sensitive
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nalysis of known targets in very small biological samples by com-
arative hybridization, a ﬁeld where other techniques like single
olecule sequencing (Harris et al., 2008; Korlach et al., 2008) and
ingle cell genomics (Kalisky and Quake, 2008) are currently too
xpensive but may  become affordable in the future. Our platform
arks a valuable technological advancement for the molecular
nalysis of small and complex heterogeneous samples such as rare
ubpopulations of highly malignant cancer cells.
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